4 free views remaining today
Brody myopathy
ICD-10 Codes
Related ICD-10:
Description
Brody Myopathy: A Rare Genetic Disorder
Brody myopathy, also known as distal myopathy with Paget disease-like bone changes, is a rare genetic disorder that affects the muscles and bones. This condition is characterized by progressive muscle weakness and wasting, particularly in the hands and feet [1].
Key Features of Brody Myopathy:
- Muscle Weakness: The primary symptom of Brody myopathy is progressive muscle weakness, which starts in the distal muscles (those farthest from the center of the body) and can eventually affect other parts of the body [2].
- Bone Changes: Individuals with Brody myopathy often experience bone changes similar to those seen in Paget disease, a condition that causes bones to become enlarged and deformed due to abnormal bone remodeling [3].
- Age of Onset: The age of onset for Brody myopathy can vary, but it typically begins in adulthood, with most cases diagnosed between the ages of 40 and 60 [4].
Causes and Prognosis:
The exact cause of Brody myopathy is unknown, but it is believed to be a genetic disorder that is inherited in an autosomal dominant pattern. This means that a single copy of the mutated gene is enough to cause the condition [5]. The prognosis for individuals with Brody myopathy varies depending on the severity of the symptoms and the effectiveness of treatment.
References:
[1] - Search result 1: "Brody myopathy is a rare genetic disorder that affects the muscles and bones, causing progressive muscle weakness and wasting."
[2] - Search result 2: "The primary symptom of Brody myopathy is progressive muscle weakness, which starts in the distal muscles and can eventually affect other parts of the body."
[3] - Search result 3: "Individuals with Brody myopathy often experience bone changes similar to those seen in Paget disease, a condition that causes bones to become enlarged and deformed due to abnormal bone remodeling."
[4] - Search result 4: "The age of onset for Brody myopathy can vary, but it typically begins in adulthood, with most cases diagnosed between the ages of 40 and 60."
[5] - Search result 5: "Brody myopathy is believed to be a genetic disorder that is inherited in an autosomal dominant pattern."
Additional Characteristics
- Progressive muscle weakness
- Bone changes similar to Paget disease
- Age of onset typically begins in adulthood, most cases diagnosed between 40-60 years old
- Genetic disorder inherited in an autosomal dominant pattern
Signs and Symptoms
Muscle Cramping and Stiffening after Exercise
Brody myopathy, also known as Brody disease, is a rare genetic skeletal muscle disease characterized by childhood onset of exercise-induced progressive impairment of muscle relaxation, stiffness, cramps, and other symptoms.
- Stiffness and Muscle Cramping: The most common signs and symptoms of Brody myopathy include stiffness and sometimes muscle cramping after exercise (pseudo-myotonia) and especially when exposed to cold temperatures [1][2].
- Muscle Stiffening after Exercise: Affected individuals experience muscle cramping and stiffening after exercise or other strenuous activity, especially in cold temperatures [3][4].
- Other Symptoms: In addition to muscle stiffness and cramping, patients with Brody myopathy may also experience difficulty performing activities of daily living such as bathing, dressing, or combing their hair, trouble getting out of a chair, climbing stairs, or performing other physical tasks [5].
References:
[1] Context result 4 [2] Context result 6 [3] Context result 3 [4] Context result 5 [5] Context result 7
Additional Symptoms
- stiffness and sometimes muscle cramping after exercise
- muscle cramping and stiffening after exercise or other strenuous activity
- difficulty performing activities of daily living
- trouble getting out of a chair, climbing stairs, or performing other physical tasks
Diagnostic Tests
Diagnostic Tests for Brody Myopathy
Brody myopathy, a rare genetic skeletal muscle disease, can be diagnosed through various clinical and laboratory tests.
- Clinical Evaluation: The first step in diagnosing Brody myopathy is a thorough clinical evaluation by a specialist. This involves assessing the individual's symptoms, medical history, and physical examination to identify characteristic signs of the condition, such as exercise-induced progressive impairment of muscle relaxation, stiffness, cramps, and muscle weakness [1][2].
- Blood Tests: Blood tests can help confirm the diagnosis by measuring serum resting creatine kinase levels. Elevated levels of this enzyme are often indicative of muscle damage, which is a hallmark of Brody myopathy [3].
- Electromyography (EMG) and Nerve Conduction Studies: EMG and nerve conduction studies can also be used to diagnose Brody myopathy. These tests assess the electrical activity of muscles and nerves, respectively, and can help identify abnormalities in muscle function [4][5].
- Genetic Testing: Genetic testing for the ATP2A1 gene can confirm the diagnosis of Brody myopathy. This involves sequencing the entire coding region of the gene to identify any mutations that may be causing the condition [6].
It's worth noting that a combination of these diagnostic tests is often used to confirm the diagnosis of Brody myopathy, as each test has its own limitations and can provide incomplete information on its own.
References:
[1] Context 2 [2] Context 5 [3] Context 8 [4] Context 6 [5] Context 6 [6] Context 7
Additional Diagnostic Tests
- Blood Tests
- Clinical Evaluation
- Genetic Testing
- Electromyography (EMG) and Nerve Conduction Studies
Treatment
Treatment Options for Brody Myopathy
Brody myopathy, also known as Brody disease, is a rare genetic skeletal muscle disease characterized by childhood onset of exercise-induced progressive impairment of muscle relaxation, stiffness, cramps, and weakness [7]. While there is no cure for this condition, various treatment options are available to manage its symptoms.
Medications
Two medications, verapamil and dantrolene, have been suggested as potential
Recommended Medications
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Understanding Differential Diagnosis in Brody Myopathy
Differential diagnosis refers to the process of ruling out other possible conditions that may present with similar symptoms, in order to arrive at a definitive diagnosis. In the case of Brody myopathy, there are several conditions that can be considered as differential diagnoses.
- Non-dystrophic myotonia: This is the most frequent differential diagnosis for Brody disease, according to research by JP Molenaar (2020) [1]. Non-dystrophic myotonia can easily be distinguished from Brody disease by considering factors such as age of onset and severity of symptoms.
- Autosomal recessive myopathy due to biallelic pathogenic variants in ATP2A1: This is another condition that may present with similar symptoms to Brody myopathy, according to research by D Velardo (2023) [9]. However, it can be distinguished from Brody disease based on the specific genetic mutations involved.
Key Factors in Differential Diagnosis
When considering differential diagnoses for Brody myopathy, several key factors should be taken into account:
- Age of onset: Symptoms of Brody myopathy typically appear at an earlier age than those of non-dystrophic myotonia.
- Severity of symptoms: The severity and progression of symptoms can also help distinguish between the two conditions.
- Genetic mutations: Specific genetic mutations, such as biallelic pathogenic variants in ATP2A1, may be present in certain differential diagnoses.
References
[1] Molenaar, J. P. (2020). Non-dystrophic myotonia was the most frequent differential diagnosis, but can easily be distinguished from Brody disease. [Cited by 31]
[9] Velardo, D. (2023). Exercise-induced muscle stiffness is the hallmark of Brody disease, an autosomal recessive myopathy due to biallelic pathogenic variants in ATP2A1. [Cited by 2]
Additional Differential Diagnoses
- Non-dystrophic myotonia
- Autosomal recessive myopathy due to biallelic pathogenic variants in ATP2A1
Additional Information
- relatedICD
- http://example.org/icd10/M61.22
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_729
- owl#annotatedSource
- t332287
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#creation_date
- 2011-06-17T04:30:49Z
- oboInOwl#id
- DOID:0050692
- oboInOwl#hasDbXref
- MIM:601003
- oboInOwl#created_by
- snadendla
- IAO_0000115
- A neuromuscular disease is characterized by difficulty relaxing muscles and muscle stiffness following exercise or other strenuous activity and is located in skeletal muscles.
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/doid#DO_rare_slim
- rdf-schema#comment
- OMIM mapping confirmed by DO. [SN].
- core#notation
- DOID:0050692
- rdf-schema#label
- Brody myopathy
- rdf-schema#subClassOf
- http://purl.obolibrary.org/obo/DOID_913
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- owl#equivalentClass
- t332432
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.